+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asthma and COPD Devices Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026

  • ID: 5338236
  • Report
  • April 2021
  • Region: Global
  • 100 pages
  • Infinium Global Research

FEATURED COMPANIES

  • Aerogen, Inc.
  • AstraZeneca PLC
  • Baxter International Inc.
  • GF Health Products, Inc.
  • GlaxoSmithKline plc
  • Koninklijke Philips N.V.
The report on the global asthma and COPD devices market provides qualitative and quantitative analysis for the period from 2018 to 2026. The report predicts the global asthma and COPD devices market to grow with a CAGR of 4.7% over the forecast period from 2020-2026. The study on asthma and COPD devices market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2018 to 2026.

The report on asthma and COPD devices market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global asthma and COPD devices market over the period of 2018 to 2026. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global asthma and COPD devices market over the period of 2018 to 2026. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers
  • Rise in the prevalence of obstructive lung diseases
  • Growing geriatric population that is more susceptible to the respiratory diseases
2) Restraints
  • High cost of some inhalers and nebulizer devices
3) Opportunities
  • Transforming healthcare infrastructure in emerging markets
Research Methodology

A) Primary Research
The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with the publisher
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global asthma and COPD devices market is segmented on the basis of product, indication, and distribution channel.

The Global Asthma and COPD Devices Market by Product
  • Inhaler
  • Nebulizer
The Global Asthma and COPD Devices Market by Indication
  • Asthma
  • COPD
The Global Asthma and COPD Devices Market by Distribution Channel
  • Retail Pharmacies
  • Hospital
  • Online Pharmacies
Company Profiles
The companies covered in the report include
  • AstraZeneca PLC
  • Baxter International Inc.
  • Boehringer Ingelheim International GmbH
  • GF Health Products, Inc.
  • GlaxoSmithKline plc
  • Merck & Co.
  • Novartis AG
  • PARI GmbH
  • Koninklijke Philips N.V.
  • Aerogen, Inc.
What does this Report Deliver?
1. Comprehensive analysis of the global as well as regional markets of the asthma and COPD devices market.
2. Complete coverage of all the segments in the asthma and COPD devices market to analyze the trends, developments in the global market and forecast of market size up to 2026.
3. Comprehensive analysis of the companies operating in the global asthma and COPD devices market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aerogen, Inc.
  • AstraZeneca PLC
  • Baxter International Inc.
  • GF Health Products, Inc.
  • GlaxoSmithKline plc
  • Koninklijke Philips N.V.
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Asthma and COPD Devices Market Highlights
2.2. Asthma and COPD Devices Market Projection
2.3. Asthma and COPD Devices Market Regional Highlights

3. Global Asthma and COPD Devices Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Analysis of COVID-19 impact on the Asthma and COPD Devices Market
3.4. Porter's Five Forces Analysis
3.5. Growth Matrix Analysis
3.5.1. Growth Matrix Analysis by Product
3.5.2. Growth Matrix Analysis by Indication
3.5.3. Growth Matrix Analysis by Distribution Channel
3.5.4. Growth Matrix Analysis by Region
3.6. Value Chain Analysis of Asthma and COPD Devices Market

4. Asthma and COPD Devices Market Macro Indicator Analysis

5. Global Asthma and COPD Devices Market by Product
5.1. Inhaler
5.2. Nebulizer

6. Global Asthma and COPD Devices Market by Indication
6.1. Asthma
6.2. COPD

7. Global Asthma and COPD Devices Market by Distribution Channel
7.1. Retail Pharmacies
7.2. Hospital
7.3. Online Pharmacies

8. Global Asthma and COPD Devices Market by Region 2020-2026
8.1. North America
8.1.1. North America Asthma and COPD Devices Market by Product
8.1.2. North America Asthma and COPD Devices Market by Indication
8.1.3. North America Asthma and COPD Devices Market by Distribution Channel
8.1.4. North America Asthma and COPD Devices Market by Country
8.2. Europe
8.2.1. Europe Asthma and COPD Devices Market by Product
8.2.2. Europe Asthma and COPD Devices Market by Indication
8.2.3. Europe Asthma and COPD Devices Market by Distribution Channel
8.2.4. Europe Asthma and COPD Devices Market by Country
8.3. Asia-Pacific
8.3.1. Asia-Pacific Asthma and COPD Devices Market by Product
8.3.2. Asia-Pacific Asthma and COPD Devices Market by Indication
8.3.3. Asia-Pacific Asthma and COPD Devices Market by Distribution Channel
8.3.4. Asia-Pacific Asthma and COPD Devices Market by Country
8.4. RoW
8.4.1. RoW Asthma and COPD Devices Market by Product
8.4.2. RoW Asthma and COPD Devices Market by Indication
8.4.3. RoW Asthma and COPD Devices Market by Distribution Channel
8.4.4. RoW Asthma and COPD Devices Market by Sub-region

9. Company Profiles and Competitive Landscape
9.1. Competitive Landscape in the Global Asthma and COPD Devices Market
9.2. Companies Profiled
9.2.1. AstraZeneca PLC
9.2.2. Baxter International Inc.
9.2.3. Boehringer Ingelheim International GmbH
9.2.4. GF Health Products, Inc.
9.2.5. GlaxoSmithKline plc
9.2.6. Merck & Co.
9.2.7. Novartis AG
9.2.8. PARI GmbH
9.2.9. Koninklijke Philips N.V.
9.2.10. Aerogen, Inc.
Note: Product cover images may vary from those shown
  • AstraZeneca PLC
  • Baxter International Inc.
  • Boehringer Ingelheim International GmbH
  • GF Health Products, Inc.
  • GlaxoSmithKline plc
  • Merck & Co.
  • Novartis AG
  • PARI GmbH
  • Koninklijke Philips N.V.
  • Aerogen, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll